KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS

TO THE EDITORS About KDventures AB KDventures AB (Nasdaq Stockholm: KDV) is a Nordic investment company specialized in life sciences. The company identifies and invests in innovative pharmaceutical projects and medical technology products originating from leading research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, KDventures creates value from early research to commercialization. The compan ...